Influence of epilepsy and antiepileptic drug intake in patients suffering from aneurysmal subarachnoid hemorrhage on outcome
Brain and Spine · 2026 · 6 · 105924
DOI: 10.1016/j.bas.2025.105924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Spine, 2026. Verfasst von Tim Lampmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Bonn, Venusberg Campus 1, Bonn, 53127, Germany. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Many patients suffering from aneurysmal subarachnoid hemorrhage (SAH) develop epileptic seizures. The recent guidelines do not recommend routine administration of antiepileptic drugs (AED). Research question: We performed a retrospective single-center study to analyze the effect of AEDs on the outcome in patients suffering from epilepsy after SAH.
Methods
752 patients with SAH treated between 01/2006 and 12/2020 were analyzed. Patients were divided into good-grade (WFNS grades I-II) versus poor-grade (WFNS grades III-V) on admission. Data of patients' history as well as clinical course were collected. Outcome according to the modified Rankin scale (mRS) score was assessed at 6 months after ictus. Outcome was dichotomized into favorable (mRS 0-2) and unfavorable (mRS 3-6). Univariate and multivariate analyses were performed.
Results
346 (46.0 %) patients suffered from poor-grade SAH and 366 (48.7 %) patients achieved unfavorable outcome. 202 (26.9 %) patients suffered from seizures after SAH and 136 (18.1 %) had to be treated with antiepileptic drugs (AEDs) for more than a week. Epilepsy and AED intake after 3 months was more often in patients with unfavorable outcome (18.9 % vs. 8.3 %; p 50 years' (p = 0.001, OR 2.7, 95 % CI 1.5-4.8, 'aneurysm size >10 mm' (p = 0.018, OR 2.2, 95 % CI 1.1-4.1), 'hydrocephalus' (p = 0.002, OR 2.6, 95 % CI 1.4-4.7), 'delayed cerebral ischemia' (p = 0.002, OR 5.0, 95 % CI 2.3-10.9) and 'epilepsy within 3 months' (p = 0.002, OR 5.9, 95 % CI 1.9-18.3) were predictors for unfavorable outcome, whereas 'AED intake after 6 months' (p = 0.037, OR 0.35, 95 % CI 0.13-0.94) was predictor for favorable outcome.
Conclusions
Manifestation of epilepsy in patients suffering from SAH deteriorates outcome. Continued AED intake in SAH patients who developed epileptic seizures should be advised.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University Hospital Bonn, Venusberg Campus 1, Bonn, 53127, Germany.
- Neurological Rehabilitation Center Godeshöhe, Waldstraße 2-10, Bonn, 53177, Germany.
Zitieren
APA
Lampmann, T., Asoglu, H., Alenezi, H., Jaber, M., Otto, B., Banat, M., Güresir, E., Vatter, H., & Hamed, M. (2026). Influence of epilepsy and antiepileptic drug intake in patients suffering from aneurysmal subarachnoid hemorrhage on outcome. Brain and Spine, 6, 105924. https://doi.org/10.1016/j.bas.2025.105924
Vancouver
Lampmann T, Asoglu H, Alenezi H, Jaber M, Otto B, Banat M, et al. Influence of epilepsy and antiepileptic drug intake in patients suffering from aneurysmal subarachnoid hemorrhage on outcome. Brain and Spine. 2026;6:105924. doi:10.1016/j.bas.2025.105924
BibTeX
@article{Lampmann2026,
author = {Lampmann, Tim and Asoglu, Harun and Alenezi, Haitham and Jaber, Mohammed and Otto, Bettina and Banat, Mohammed and Güresir, Erdem and Vatter, Hartmut and Hamed, Motaz},
title = {Influence of epilepsy and antiepileptic drug intake in patients suffering from aneurysmal subarachnoid hemorrhage on outcome},
journal = {Brain and Spine},
year = {2026},
volume = {6},
pages = {105924},
doi = {10.1016/j.bas.2025.105924}
}
EUVIMED